Resistance to Met inhibitors in MET-addicted gastric cancer cell lines is sustained by Myc, and the double blockade of Met and Myc can lessen the tumor growth of MET-amplified patient-derived xenografts tumors [28]. The gene discussed is MET; the disease is gastric cancer.